Literature DB >> 33283648

Effects of intravesical prostaglandin E2 on bladder function are preserved in capsaicin-desensitized rats.

James A Hokanson1, Christopher L Langdale1, Philip H Milliken2, Arun Sridhar2, Warren M Grill1,3,4,5.   

Abstract

Prostaglandin E2 (PGE2) instilled into the bladder generates symptoms of urinary urgency in healthy women and reduces bladder capacity and urethral pressure in both humans and female rats. Systemic capsaicin desensitization, which causes degeneration of C-fibers, prevented PGE2-mediated reductions in bladder capacity, suggesting that PGE2 acts as an irritant (Maggi CA, Giuliani S, Conte B, Furio M, Santicioli P, Meli P, Gragnani L, Meli A. Eur J Pharmacol 145: 105-112, 1988). In the present study, we instilled PGE2 in female rats after capsaicin desensitization but without the hypogastric nerve transection that was conducted in the Maggi et al. study. One week after capsaicin injection (125 mg/kg sc), rats underwent cystometric and urethral perfusion testing under urethane anesthesia with saline and 100 µM PGE2. Similar to naïve rats, capsaicin-desensitized rats exhibited a reduction in bladder capacity from 1.23 ± 0.08 mL to 0.70 ± 0.10 mL (P = 0.002, n = 9), a reduction in urethral perfusion pressure from 19.3 ± 2.1 cmH2O to 10.9 ± 1.2 cmH2O (P = 0.004, n = 9), and a reduction in bladder compliance from 0.13 ± 0.020 mL/cmH2O to 0.090 ± 0.014 mL/cmH2O (P = 0.011, n = 9). Thus, changes in bladder function following the instillation of PGE2 were not dependent on capsaicin-sensitive pathways. Further, these results suggest that urethral relaxation/weakness and/or increased detrusor pressure as a result of decreased compliance may contribute to urinary urgency and highlight potential targets for new therapies for overactive bladder.

Entities:  

Keywords:  capsaicin; overactive bladder; prostaglandin E2; urethra; urinary urgency

Mesh:

Substances:

Year:  2020        PMID: 33283648      PMCID: PMC7948121          DOI: 10.1152/ajprenal.00302.2020

Source DB:  PubMed          Journal:  Am J Physiol Renal Physiol        ISSN: 1522-1466


  43 in total

1.  Clinical and experimental studies on the action of prostaglandins and their synthesis inhibitors on detrusor muscle in vitro and in vivo.

Authors:  M I Bultitude; N H Hills; K E Shuttleworth
Journal:  Br J Urol       Date:  1976

Review 2.  Capsaicin: actions on nociceptive C-fibres and therapeutic potential.

Authors:  B Lynn
Journal:  Pain       Date:  1990-04       Impact factor: 6.961

3.  Enhanced sensitivity to afferent stimulation and impact of overactive bladder therapies in the conscious, spontaneously hypertensive rat.

Authors:  Phani B Patra; Kevin S Thorneloe
Journal:  J Pharmacol Exp Ther       Date:  2011-04-26       Impact factor: 4.030

4.  Altered urinary bladder function in mice lacking the vanilloid receptor TRPV1.

Authors:  L A Birder; Y Nakamura; S Kiss; M L Nealen; S Barrick; A J Kanai; E Wang; G Ruiz; W C De Groat; G Apodaca; S Watkins; M J Caterina
Journal:  Nat Neurosci       Date:  2002-09       Impact factor: 24.884

5.  Further studies on mechanisms regulating the voiding cycle of the rat urinary bladder.

Authors:  C A Maggi; B Conte; M Furio; P Santicioli; S Giuliani; A Meli
Journal:  Gen Pharmacol       Date:  1989

6.  Prostaglandin E2 and bethanechol in combination for treating detrusor underactivity.

Authors:  R G Hindley; R D Brierly; P J Thomas
Journal:  BJU Int       Date:  2004-01       Impact factor: 5.588

7.  Effects of CL316,243, a beta 3-adrenoceptor agonist, and intravesical prostaglandin E2 on the primary bladder afferent activity of the rat.

Authors:  Naoki Aizawa; Yasuhiko Igawa; Osamu Nishizawa; Jean-Jacques Wyndaele
Journal:  Neurourol Urodyn       Date:  2010-06       Impact factor: 2.696

8.  Intravesical protamine sulfate and potassium chloride as a model for bladder hyperactivity.

Authors:  Yao-Chi Chuang; Michael B Chancellor; Satoshi Seki; Naoki Yoshimura; Pradeep Tyagi; Leaf Huang; John P Lavelle; William C De Groat; Matthew O Fraser
Journal:  Urology       Date:  2003-03       Impact factor: 2.649

9.  Modulation of afferent nerve activity by prostaglandin E2 upon urinary bladder distension in rats.

Authors:  Nahoko Kuga; Asao Tanioka; Koichiro Hagihara; Tomoyuki Kawai
Journal:  Exp Physiol       Date:  2016-03-15       Impact factor: 2.969

10.  Urinary K+ promotes irritative voiding symptoms and pain in the face of urothelial barrier dysfunction.

Authors:  Nicolas Montalbetti; Sean D Stocker; Gerard Apodaca; Sheldon I Bastacky; Marcelo D Carattino
Journal:  Sci Rep       Date:  2019-04-02       Impact factor: 4.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.